AU2001275095A1 - Single-patient drug trials used with accumulated database - Google Patents

Single-patient drug trials used with accumulated database

Info

Publication number
AU2001275095A1
AU2001275095A1 AU2001275095A AU7509501A AU2001275095A1 AU 2001275095 A1 AU2001275095 A1 AU 2001275095A1 AU 2001275095 A AU2001275095 A AU 2001275095A AU 7509501 A AU7509501 A AU 7509501A AU 2001275095 A1 AU2001275095 A1 AU 2001275095A1
Authority
AU
Australia
Prior art keywords
patient drug
drug trials
trials used
accumulated database
accumulated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001275095A
Inventor
Donald P. Reitberg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Opt-e-scrip Inc
Original Assignee
Opt-e-scrip Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Opt-e-scrip Inc filed Critical Opt-e-scrip Inc
Publication of AU2001275095A1 publication Critical patent/AU2001275095A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • G16H10/20—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for electronic clinical trials or questionnaires
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G16B20/20—Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING OR COUNTING
    • G06Q—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES, NOT OTHERWISE PROVIDED FOR
    • G06Q10/00—Administration; Management
    • G06Q10/10—Office automation; Time management
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/30—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to physical therapies or activities, e.g. physiotherapy, acupressure or exercising
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H70/00—ICT specially adapted for the handling or processing of medical references
    • G16H70/60—ICT specially adapted for the handling or processing of medical references relating to pathologies
AU2001275095A 2000-07-17 2001-06-01 Single-patient drug trials used with accumulated database Abandoned AU2001275095A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US21899400P 2000-07-17 2000-07-17
US60218994 2000-07-17
PCT/US2001/017700 WO2002006826A1 (en) 2000-07-17 2001-06-01 Single-patient drug trials used with accumulated database

Publications (1)

Publication Number Publication Date
AU2001275095A1 true AU2001275095A1 (en) 2002-01-30

Family

ID=22817344

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001275095A Abandoned AU2001275095A1 (en) 2000-07-17 2001-06-01 Single-patient drug trials used with accumulated database

Country Status (3)

Country Link
US (2) US20020038310A1 (en)
AU (1) AU2001275095A1 (en)
WO (1) WO2002006826A1 (en)

Families Citing this family (99)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090150192A1 (en) * 1998-03-10 2009-06-11 Discovery Holdings Limited Method and system for calculating the premiums and benefits of life insurance and related risk products based on participation in a wellness program
US8131570B2 (en) * 1998-03-10 2012-03-06 Discovery Holdings Limited Managing the business of a medical insurance plan
US8359208B2 (en) 1999-03-09 2013-01-22 Discover Holdings Limited Wellness program management and integration with payroll vendor systems
US6640211B1 (en) * 1999-10-22 2003-10-28 First Genetic Trust Inc. Genetic profiling and banking system and method
US8306899B2 (en) * 2000-08-07 2012-11-06 Discovery Life Ltd. Managing a life insurance investment
US20020046054A1 (en) * 2000-08-28 2002-04-18 Morand Patrick G. Use of blood and plasma donor samples and data in the drug discovery process
GB2369778A (en) * 2000-09-06 2002-06-12 Discovery Health Ltd Incentivising compliance in members of a disease management programme
US8352291B2 (en) * 2000-09-26 2013-01-08 Rubenstein Joel J Innovations in health insurance
US20020143579A1 (en) * 2001-03-30 2002-10-03 Docherty John P. System and method for targeted interventions of physician prescription practices based on deviations from expert guidelines
US20020156651A1 (en) * 2001-04-18 2002-10-24 Florio Vito V. Prescription system for unregulated therapeutic substances
US8329216B2 (en) * 2001-07-06 2012-12-11 Endo Pharmaceuticals Inc. Oxymorphone controlled release formulations
EP1404333A1 (en) * 2001-07-06 2004-04-07 Endo Pharmaceuticals Inc. Oxymorphone controlled release formulations
DE10141650C1 (en) 2001-08-24 2002-11-28 Lohmann Therapie Syst Lts Safe transdermal therapeutic system for administration of fentanyl or analogous analgesics, having matrix layer of carboxy group-free polyacrylate adhesive providing high permeation rate
US20030091635A1 (en) * 2001-09-26 2003-05-15 Baichwal Anand R. Opioid formulations having reduced potential for abuse
WO2003036590A1 (en) 2001-10-26 2003-05-01 Concordant Rater Systems Llc Computer system and method for training, certifying or monitoring human clinical raters
JP2005509218A (en) * 2001-11-02 2005-04-07 シーメンス　メディカル　ソリューションズ　ユーエスエー　インコーポレイテッド Patient data mining to maintain quality
US7457731B2 (en) * 2001-12-14 2008-11-25 Siemens Medical Solutions Usa, Inc. Early detection of disease outbreak using electronic patient data to reduce public health threat from bio-terrorism
US20030149595A1 (en) * 2002-02-01 2003-08-07 Murphy John E. Clinical bioinformatics database driven pharmaceutical system
US8620677B2 (en) * 2002-04-09 2013-12-31 Pcrs, Inc. Online, interactive evaluation of research performance
US7680086B2 (en) * 2002-09-09 2010-03-16 Siemens Canada Limited Wireless local area network with clients having extended freedom of movement
WO2009027843A2 (en) * 2007-05-18 2009-03-05 Optimata Ltd. Techniques for purposing a new compound and for repurposing a drug
US7908156B2 (en) * 2002-09-20 2011-03-15 Discovery Holdings Limited Method of calculating a premium payable by an insured person on a life insurance policy
US7870006B2 (en) * 2002-09-23 2011-01-11 General Electric Company Methods and systems for managing clinical research information
US7668730B2 (en) 2002-12-17 2010-02-23 JPI Commercial, LLC. Sensitive drug distribution system and method
US20040181429A1 (en) * 2003-03-14 2004-09-16 Electronic Data Systems Corporation Method and system for administering a drug
US20040220833A1 (en) * 2003-04-15 2004-11-04 Matthias Joseph A. System and method for monitoring efficacy of web-based online behavioral clinical study
GB0322661D0 (en) * 2003-05-01 2003-10-29 Aventis Pharma Inc System and method for enhanced medicament-based treatment of disease
US7499866B2 (en) * 2003-05-19 2009-03-03 Threewire, Inc. Method for direct-to-patient marketing and clinical trials recruitment with outcomes tracking and method for confidential appointment booking
AU2005201382A1 (en) * 2004-04-01 2005-10-20 Discovery Life Limited A method of managing a life insurance policy and a system therefor
ZA200501719B (en) * 2004-04-16 2006-11-29 Discovery Life Ltd Methods of managing a life insurance policy with a related medical scheme
CN101027689A (en) * 2004-07-26 2007-08-29 发现控股有限公司 A data processing system for accurately calculating a policyholder's discount in a medical insurance plan and a method therefor
US8055511B2 (en) * 2004-12-29 2011-11-08 Cerner Innovation, Inc. System and methods for providing medication selection guidance
WO2006072822A2 (en) * 2005-01-07 2006-07-13 Discovery Holdings Limited A method of managing the business of a health insurance plan and a system therefor
US20080275731A1 (en) * 2005-05-18 2008-11-06 Rao R Bharat Patient data mining improvements
WO2007102077A2 (en) * 2006-03-07 2007-09-13 Discovery Holdings Limited A system and method of managing absenteeism in an organisation
US20070212414A1 (en) * 2006-03-08 2007-09-13 Penwest Pharmaceuticals Co. Ethanol-resistant sustained release formulations
US20090259497A1 (en) * 2006-06-06 2009-10-15 Adrian Gore Method of managing an insurance plan and a system therefor
WO2007141695A2 (en) 2006-06-07 2007-12-13 Discovery Holdings Limited A system and method of managing an insurance scheme
WO2007141697A2 (en) * 2006-06-07 2007-12-13 Discovery Holdings Limited A method of managing a life insurance plan and a system therefor
AU2007298514A1 (en) * 2006-09-18 2008-03-27 Discovery Holdings Limited A method of managing the wellness of an organisation and a system therefor
US20080154650A1 (en) * 2006-09-22 2008-06-26 Shaun Matisonn Method of managing the business of a health insurance plan and a system therefor
US20100023384A1 (en) * 2006-09-26 2010-01-28 Discovery Holdings Limited System and method for rewarding employees of an organisation
US20080133267A1 (en) * 2006-11-30 2008-06-05 George Maltezos System and method for individualized patient care
US20090124650A1 (en) * 2007-06-21 2009-05-14 Endo Pharmaceuticals, Inc. Method of Treating Pain Utilizing Controlled Release Oxymorphone Pharmaceutical Compositions and Instructions on Effects of Alcohol
US20080318993A1 (en) * 2007-06-21 2008-12-25 Endo Pharmaceuticals, Inc. Method of Treating Pain Utilizing Controlled Release Oxymorphone Pharmaceutical Compositions and Instruction on Dosing for Hepatic Impairment
US20080318994A1 (en) * 2007-06-21 2008-12-25 Endo Pharmaceuticals, Inc. Method of Treating Pain Utilizing Controlled Release Oxymorphone Pharmaceutical Compositions and Instruction on Dosing for Renal Impairment
EP3922171A1 (en) 2007-09-14 2021-12-15 Medtronic Monitoring, Inc. Adherent cardiac monitor with advanced sensing capabilities
US8116841B2 (en) 2007-09-14 2012-02-14 Corventis, Inc. Adherent device with multiple physiological sensors
EP2200512A1 (en) 2007-09-14 2010-06-30 Corventis, Inc. Adherent device for respiratory monitoring and sleep disordered breathing
WO2009036316A1 (en) 2007-09-14 2009-03-19 Corventis, Inc. Energy management, tracking and security for adherent patient monitor
EP2200499B1 (en) 2007-09-14 2019-05-01 Medtronic Monitoring, Inc. Multi-sensor patient monitor to detect impending cardiac decompensation
US9186089B2 (en) 2007-09-14 2015-11-17 Medtronic Monitoring, Inc. Injectable physiological monitoring system
EP2194858B1 (en) 2007-09-14 2017-11-22 Corventis, Inc. Medical device automatic start-up upon contact to patient tissue
EP2257216B1 (en) 2008-03-12 2021-04-28 Medtronic Monitoring, Inc. Heart failure decompensation prediction based on cardiac rhythm
US8412317B2 (en) 2008-04-18 2013-04-02 Corventis, Inc. Method and apparatus to measure bioelectric impedance of patient tissue
CN102057391A (en) * 2008-06-03 2011-05-11 发现控股有限公司 A system and method of managing an insurance scheme
CN102057393A (en) * 2008-06-03 2011-05-11 发现控股有限公司 A system and method of managing an insurance scheme
CN102057390A (en) * 2008-06-03 2011-05-11 发现控股有限公司 A system and method of managing an insurance scheme
WO2009147593A1 (en) * 2008-06-03 2009-12-10 Discovery Holdings Limited A system and method of managing an insurance scheme
WO2009147594A1 (en) * 2008-06-03 2009-12-10 Discovery Holdings Limited A system and method of managing an insurance scheme
EP2352479A4 (en) * 2008-11-05 2012-09-05 Stephen B Gold Method and system to control and enhance prescribing and dispensing of medication
US8131568B2 (en) 2009-03-11 2012-03-06 Discovery Holdings Limited Method and system for operating an insurance program to insure a performance bonus of a person
RU2012117561A (en) * 2009-09-29 2013-11-10 Новартис Аг METHOD AND SYSTEM OF ACCESS TO PATIENT DATA
US8790259B2 (en) 2009-10-22 2014-07-29 Corventis, Inc. Method and apparatus for remote detection and monitoring of functional chronotropic incompetence
WO2011051873A2 (en) * 2009-10-26 2011-05-05 Discovery Life Limited A system and method of managing an insurance scheme
US9451897B2 (en) 2009-12-14 2016-09-27 Medtronic Monitoring, Inc. Body adherent patch with electronics for physiologic monitoring
US8346710B2 (en) * 2010-01-29 2013-01-01 Google Inc. Evaluating statistical significance of test statistics using placebo actions
US8965498B2 (en) 2010-04-05 2015-02-24 Corventis, Inc. Method and apparatus for personalized physiologic parameters
US8768724B2 (en) * 2010-04-27 2014-07-01 The Travelers Indemnity Company System and method for detecting drug fraud and abuse
US10943676B2 (en) 2010-06-08 2021-03-09 Cerner Innovation, Inc. Healthcare information technology system for predicting or preventing readmissions
EP2479691A1 (en) * 2011-01-21 2012-07-25 Johan Cederlund Pharmaceutical product and communication tool
US20150371007A1 (en) * 2011-01-21 2015-12-24 Scientificmed Sweden Ab Pharmaceutical product and communication tool
US20140011178A1 (en) 2012-07-03 2014-01-09 ePreventions, LLC Prevention and intervention assistance system
SE1250894A1 (en) * 2012-07-24 2014-01-25 Johan Cederlund Improved drug and communication tools
US9265458B2 (en) 2012-12-04 2016-02-23 Sync-Think, Inc. Application of smooth pursuit cognitive testing paradigms to clinical drug development
ZA201308624B (en) 2012-12-21 2015-02-25 Destiny Health Inc A method of determining the attendance of an individual at a location and a system therefor
US10262112B2 (en) 2013-02-04 2019-04-16 Precera Bioscience, Inc. Prescription decision support system and method using comprehensive multiplex drug monitoring
US20140229191A1 (en) * 2013-02-04 2014-08-14 Sano Informed Prescribing, Llc Prescription decision support system and method using comprehensive multiplex drug monitoring
US9380976B2 (en) 2013-03-11 2016-07-05 Sync-Think, Inc. Optical neuroinformatics
EP3090390A4 (en) * 2014-01-03 2018-01-17 Health: Elt, LLC Method and system for engagement, logistics, and technology for health services
US9922307B2 (en) 2014-03-31 2018-03-20 Elwha Llc Quantified-self machines, circuits and interfaces reflexively related to food
US10127361B2 (en) 2014-03-31 2018-11-13 Elwha Llc Quantified-self machines and circuits reflexively related to kiosk systems and associated food-and-nutrition machines and circuits
US10318123B2 (en) 2014-03-31 2019-06-11 Elwha Llc Quantified-self machines, circuits and interfaces reflexively related to food fabricator machines and circuits
US20150279178A1 (en) * 2014-03-31 2015-10-01 Elwha Llc Quantified-self machines and circuits reflexively related to fabricator, big-data analytics and user interfaces, and supply machines and circuits
CN107111673B (en) * 2014-09-29 2021-03-23 周格尼克斯国际有限公司 Control system for controlling the dispensing of a medicament
US20160259890A1 (en) * 2015-03-03 2016-09-08 Curamatix Clinical Solutions Method for development of a clinical database, and application of statistical probability estimation methods for design and analysis of clinical studies and assesment of treatment metrics
CA3007673A1 (en) 2015-12-22 2017-06-29 Zogenix International Limited Metabolism resistant fenfluramine analogs and methods of using the same
DK3393655T3 (en) 2015-12-22 2021-03-15 Zogenix International Ltd FENFLURAMIN COMPOSITIONS AND METHODS FOR THE PREPARATION OF THE SAME
MX2019001799A (en) 2016-08-24 2019-06-13 Zogenix International Ltd Formulation for inhibiting formation of 5-ht 2b agonists and methods of using same.
US11456081B1 (en) 2017-07-20 2022-09-27 Jazz Pharmaceuticals, Inc. Sensitive drug distribution systems and methods
US10682317B2 (en) 2017-09-26 2020-06-16 Zogenix International Limited Ketogenic diet compatible fenfluramine formulation
CN108022632A (en) * 2017-12-20 2018-05-11 中国科学院合肥物质科学研究院 A kind of bone health promotion system based on stress regulation and control
US20200395103A1 (en) * 2018-02-21 2020-12-17 Klaritos, Inc. Methods of performing clinical trials
JP2021526507A (en) 2018-05-11 2021-10-07 ゾゲニクス インターナショナル リミテッド Compositions and Methods for Treating Sudden Death Induced by Seizures
CN109589092B (en) * 2018-10-08 2021-06-08 潘丹 Alzheimer disease determination method and system based on ensemble learning
US11748800B1 (en) * 2019-09-11 2023-09-05 Life Spectacular, Inc. Generating skin care recommendations for a user based on skin product attributes and user location and demographic data
US11612574B2 (en) 2020-07-17 2023-03-28 Zogenix International Limited Method of treating patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
US11581084B2 (en) * 2020-12-29 2023-02-14 Kpn Innovations, Llc. Systems and methods for generating an alimentary plan for managing skin disorders
US11907305B1 (en) * 2021-07-09 2024-02-20 Veeva Systems Inc. Systems and methods for analyzing adverse events of a source file and arranging the adverse events on a user interface

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5594637A (en) * 1993-05-26 1997-01-14 Base Ten Systems, Inc. System and method for assessing medical risk
US6242463B1 (en) * 1994-10-31 2001-06-05 Opt-E-Scrip, Inc. Method and kit for treating illnesses
US5991637A (en) * 1996-04-19 1999-11-23 Mack, Ii; Gawins A. Integrated passive and active communications system
US6177244B1 (en) * 1996-05-10 2001-01-23 Beth Israel Deaconess Medical Center Inc. NPG-1 gene that is differentially expressed in prostate tumors
WO1998012669A1 (en) * 1996-09-18 1998-03-26 Pharm-Data, Inc. Method and apparatus for processing clinical trial databases
US6180114B1 (en) * 1996-11-21 2001-01-30 University Of Washington Therapeutic delivery using compounds self-assembled into high axial ratio microstructures
JPH10214294A (en) * 1997-01-30 1998-08-11 Mosu:Kk Clinical trial report preparation system
AU6047498A (en) * 1997-03-03 1998-09-22 University Of Florida Method and system for interactive prescription and distribution of drugs in conducting medical studies
US6029138A (en) * 1997-08-15 2000-02-22 Brigham And Women's Hospital Computer system for decision support in the selection of diagnostic and therapeutic tests and interventions for patients

Also Published As

Publication number Publication date
WO2002006826B1 (en) 2002-04-04
WO2002006826A1 (en) 2002-01-24
US20020038310A1 (en) 2002-03-28
US20020032581A1 (en) 2002-03-14

Similar Documents

Publication Publication Date Title
AU2001275095A1 (en) Single-patient drug trials used with accumulated database
AU2002226072A1 (en) Value-instance-connectivity-computer-implemented database
AU2002224520A1 (en) A cannula
AU2001241423A1 (en) Needleless syringe
AU2002330273A1 (en) Liposome-encapsulated insulin formulations
AU2001274548A1 (en) Syringe
AU2001278755A1 (en) Injections
AU2002253039A1 (en) Tramadol-based medicament
AU2002359919A1 (en) Syringe
AUPR054400A0 (en) A castor
AU2002361092A1 (en) Syringe
EP1272240B8 (en) Hypodermic syringe
AU2001289711A1 (en) Plunger syringe
AU2002221099A1 (en) Combination drugs
AU2001232244A1 (en) Drug comprising combination
AU2001260236A1 (en) Restricted use syringe
AUPR960001A0 (en) A syringe
AU2002349142A1 (en) Syringe
AU2001288501A1 (en) Reference database
AU2001270903A1 (en) Needleless syringe
AUPQ864900A0 (en) A syringe
AU2001253798A1 (en) A database arrangement
AU2001260789A1 (en) Wheelchair
AUPR360501A0 (en) A chair
AUPR278601A0 (en) A syringe